GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

When Jenni* started using a medication called liraglutide to lose weight, she noticed changes not just in her appetite, but ...

Despite the promising results, further research is needed before GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists ...

The rise of GLP-1s (glucagon-like peptides) has revolutionized obesity management. These medications help people shed pounds ...

Researchers analysed data from 150 adults with T1D, divided into semaglutide, tirzepatide, and control groups.

The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.

This came after Alkem Laboratories presented BE study protocol vide no. BIOS/2024/128, Version No. 01, Dated 17.07.2024 and ...

This came after Hetero Labs presented the BE study protocol, vide no. AZBE112405, Version No. 01, Dated 15.11.2024 and the ...

Ozempic, a medication for type 2 diabetes and weight loss, mimics the action of GLP-1 to regulate blood sugar and appetite.

The story of one huge advance in health care shows why public investment in science is critical and why proposed cuts are ...